Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease.
Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease.
复制标题
DOI:
10.1159/000514578
复制
发表时间:
2021
影响因子:
4.2
通讯作者:
Pezzolesi MG
中科院分区:
文献类型:
--
作者:
Lazaro-Guevara J;Fierro-Morales J;Wright AH;Gunville R;Simeone C;Frodsham SG;Pezzolesi MH;Zaffino CA;Al-Rabadi L;Ramkumar N;Pezzolesi MG
Diabetes is the most common cause of chronic kidney disease (CKD). For patients with diabetes and CKD, the underlying cause of their kidney disease is often assumed to be a consequence of their diabetes. Without histopathological confirmation, however, the underlying cause of their disease is unclear. Recent studies have shown that next-generation sequencing (NGS) provides a promising avenue toward uncovering and establishing precise genetic diagnoses in various forms of kidney disease. Here, we set out to investigate the genetic basis of disease in non-diabetic kidney disease (NDKD) and diabetic kidney disease (DKD) patients by performing targeted NGS using a custom panel comprised of 345 kidney disease-related genes. Our analysis identified rare diagnostic variants based on ACMG-AMP guidelines that were consistent with the clinical diagnosis of 19% of the NDKD patients included in this study. Similarly, 22% of DKD patients were found to carry rare pathogenic/likely pathogenic variants in kidney disease-related genes included on our panel. Genetic variants suggestive of NDKD were detected in 3% of the diabetic patients included in this study. Our findings suggest that rare variants in kidney disease-related genes in a diabetic background may play a role in the pathogenesis of DKD and NDKD in patients with diabetes.